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INTRODUCTION ','
Head and Neck surgical operations are often associated with major blood loss requiring substitution, usually by homologous blood transfusion since other sparing techniques such as hemodilution and intraoperative blood recuperation are usually insufficient. Furthermore, intraoperative blood recuperation has not been reported for Head and Neck cancer operations, probably because it is oncologically unsafe (1) . The risk re1ated to homologous blood transfusions are weIl known (2, 3) . ln addition of the usual . complications, sorne studies show an increase in the frequency of the cancer recurrences (4-9) and a higher incidence of postoperative infections (10, Il) . While these topics are still controversial (12) (13) (14) (15) (16) , there is growing interest in autotransfusion programs (2, 3) . Autotransfusion requires better preoperative planning, an advance knowledge of the expected blood loss, and sufficient time gap between the diagnosis and the operation. The goal of this study is to retrospectively examine the intraoperative blood loss and transfusion requirements for the various types of Head and Neck surgical procedures.
MA TERIALS AND METHODS
This is a retrospective study of patients operated in the Otolaryngology-Head and Neck Surgery Department of the University of Geneva between 1990 and. 1995. The blood bank data base was used ta identify patients receiving blood transfusions. Patients who were transfused but not operated on were @ 1998 Scandinavian University Press. ISSN 0001-6489 excluded (most of these cases were secondary to epistaxis or chemotherapy related anemia). Blood was requested for 14 types of surgical procedures. A total of 259 patients underwent one of these operations and their records were analyzed, independently of the transfusion status. Thirty two patients were excluded because their charts could not be 10-cated orbecause the information was incomplete.
A total of 227 charts were reviewed, analyzing the following parameters: the estimated intraoperative blood loss, the number of blood. units transfused during or after surgery, the age of the patient, hisjher cardiac and pulmonary medical history, the preoperative and postoperative hemoglobin and hematocrit, and the delay between diagnosis and actual surgery.
For each procedure, the parameters known before the operation were compared between transfused and non-transfused patients. Age and preoperative hemoglobin were analyzed using the Student t-test and incidence of past medical history was assessed with the X 2 test and statistics. Blood transfusion in head and neck surgery 745 Table I . Head and neck operations that required blood transfusion The operations are classified according to the localization of the primary ln order to structure our results, the different types of surgi cal operations were cIassified in 5 groups, according to the anatomical region of the primary cancer. For each procedure the average intraoperative blood 10ss, the percentage of transfused patients, and the average number oftransfused blood unitsare shown in Table 1 .
Neck dissections are usually cIassified as either radical or functional (also called modified radical neck dissection), unilateral or bilateral. Ali bilateral radical neck dissection patients required a transfusion, while only a quarter of the unilateral radical neck dissections patients were transfused. No case of functional neck dissection, unilateral or bilateral, received a transfusJOn.
The operations for oral or oropharyngeal primary cancer were ail associated with sorne form of neck dissection. One can distinguish in this group, the operations with or without mandibular resection. The mandibular resection operations included a reconstruction part with a myocutaneous or a free micro-an astomosed flap. The composite resection patients were transfused in 92% of the cases and 8 out of 10 patients with partial mandibular resection required a blood transfusion. On the other side, only 27% of glossectomy cases underwent a transfusion.
ln the laryngectomy group, the total laryngectomy or pharyngolaryngectomy patients associated with a neck dissection were transfused in 35% of cases. The total laryngectomy without neck dissection patients never required a transfusion. Only 1 out of 20 cases of partial laryngeal surgery underwent a transfusion.
The operations for paranasal sinus primaries were divided into maxillectomy cases associated or not with a cranio-facial resection, who ail necessitated a transfusion, and the lateral rhinotomy cases for which a transfusion took place only in 15% of cases.
Finally, for the total parotidectomies the rate of transfusion was 4%. There was no transfusion for a superficial parotidectomy.
Patients who had undergone previous radiation therapy had a higher blood loss, but the difference was not significant, for an y of the procedures, or for the entire patient population.
.
These results show that there are 3 categories of surgical procedures for Head and Neck cancer, according to their probability of requiring a blood transfusion. ln the first category with a high transfusion probability, a transfusion is necessary in at least 80'%ofthe patients. This category includes the bilateral radical neck dissections, the maxillectomy operations with or without a cranio-facial resection, the composite resections, and the partial mandibulectomy procedures.
For the second category, the probability is low, inferior to 5%. These operations are partial laryngectomies, parotidectomies, the functional neck dissections (unilateral or bilateral), and total laryngectomies without an associated neck dissection. ln the third category, the transfusion probability is moderate, between 15 and 40%. The procedures. involved are total laryngectomy \vith a neck dissection, glossectomy, unilateral radical neck dissections, and lateral rhinotomy. For' the moderate transfusion probability operations, patients requiring a transfusion were significantly (p < 0.001) older, with a mean age of 65 ::t 12 years, than nontransfused patients (56::t 11 years). Also, transfused patients had a lower pre ope rat ive hemoglobin (124::t Il gjl), when compared to patients not requiring a transfusion (Hb: 150::t Il gjl) and the difference was significant (p < 0.001). Finally, they had a higher incidence of cardiovascu1ar or pulmonary medical problems (80% ys. 28% for nontransfused patients).
The average preoperative hemoglobin and hematocrit for the transfused patients were respectively, 133.4 g!l and 40%. The average postoperative hemoglobin and hematocrit for the transfused patients were 101.9 g!l and 31°;;" respectively. Past medical history for cardiovascular~ll1d pulmonary diseases was present in 2YYO of transfused patients.
The delay between the diagnosis and the surgical intervention was on average 21 days: 7 days between thefirst clinic visit and the multidisciplinary tumor board and 14 da ys between this conference and the surgery date.
DISCUSSION
This retrospective study allowed us to identify and analyze the surgical procedures that required a transfusion in our cJinic. Also, the intraoperative blood 'Ioss and the transfusion requirements for each operation were determined. Overall, these results correspond to the unique study published on the subject (17) , although direct comparison is not possible because of a different classification of the primary ablative surgery and reconstruction procedure. Blood losses above 1,000 ml, which most likely require a blood transfusion, were encountered in composite resections for oral or oropharyngeal cancers, total laryngopharyngectomies, and maxillectomy procedures (17) . Like our data, these procedures were associated with a larger amount of blood units transfused.
We cou Id classify the operations according to the probability of necessitating a blood transfusion. For the procedures with a high transfusion probability, blood should be prepared beforehand because the majority of patients will require it. Inversely, preoperative blood preparation is not justifiable for the low transfusion probability operations. Finally, for the procedures with a moderate transfusion probability, our results indicate that transfused patients are older than patients who did not require a transfusion, that they have lower preoperative hemoglobin, and that they have more frequently a past medical history of cardiac and pulmonary diseases. For these operations, the probability of necessitating a blood transfusion can be evaluated by taking into account these parameters.
The preoperative hemoglobinand hematocrit values were only slightly below normal levels in our patients, showing that Head and Neck cancer patients are not anemic before surgery. Also, the low postoperative values show that our patients were not transfused in excess.
With the side effects of homologous blood transfusion in mind (2, 3), the use of autologous blood is to be considered for the operations with a high transfusion probability, as weil as for selected cases in the moderate probability group.
ln the elective surgical procedures, the delay between the decision to operate and the date of the operation can be extended to allow for the donation of adequate amount of blood (18) . The majority of operations req uiring a transfusion in Head and Neck surgery were for cancer resection. Therefore, the time available to collect blood for an autotransfusion is limited. An average delay of 3 weeks was found between the diagnosis and the date of operation. This delay appears sufficient for the donation of 2-3 blood units and this quantity of blood seems to coyer the transfusional needs for the majority of our operations. Alternatively and particularly in cases with mild anemia (hemoglobin between lOS and 125 g!l), in patients with low blood volume (body weight between 30 and 50 kg), or in patients with an operation imperatively fixed in the next 8-15 days, a pre-donation program may be facilitated by the adjuvant use of recombinant human erythropoietin (19, 20) .
The role of autotransfusion of cancer ceUs has been debated, but appear to be limited (1). Hansen et al. found apparently viable cancer cells in the venous blood during cancer resection in 26% of their patients. However, the number of circulating cancer cells was between 1 and 55, while they recovered between 10 and 107 cancer cells shed in the surgical field in 93% of the same patients. Also, the collection period follows the surgical manipulation . of the tumor and it is unclear that the number of circulating cancer cells is similar during a pre-operative collection. Probably the immunological consequences of homo logo us transfusion (21) are less detrimental than this potential risk of cancer cells autotransfusion.
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